A handful of companies are blazing a trail from reactionary to proactive medicine in a number of ways. From leveraging genome sequencing on an individual basis, to manipulating big data to mine emerging conditions across entire populations, these companies are leading the way to predict patient diagnosis intervention.
Provider facing finalists Tute Genomics, Share Practice, Chatr Health, Connexient, and Frame Health each had 5 minutes to pitch their business plan followed by 5 minutes of Q&A from our panel of expert judges.
If the technology industry has taught us anything it’s that there is no one way to do something correctly. When applying this mentality to medicine, technology innovators began to find new, creative, and cost effective ways of diagnosing patients. Now through video doctors visits, sensors, and more accessible home visits, these technology companies are changing medicine, one diagnosis at a time.